Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Related Citations for PubMed (Select 23395619)

1.

Skin cancer treatment by albumin/5-Fu loaded magnetic nanocomposite spheres in a mouse model.

Misak H, Zacharias N, Song Z, Hwang S, Man KP, Asmatulu R, Yang SY.

J Biotechnol. 2013 Mar 10;164(1):130-6. doi: 10.1016/j.jbiotec.2013.01.003. Epub 2013 Feb 7.

PMID:
23395619
2.

Cytotoxicity of release products from magnetic nanocomposites in targeted drug delivery.

Wamocha HL, Misak HE, Song Z, Chu HY, Chen YY, Asmatulu R, Yang SY, Ho JC.

J Biomater Appl. 2013 Feb;27(6):661-7. doi: 10.1177/0885328211421989. Epub 2011 Nov 9.

PMID:
22071353
3.

Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.

Nair K L, Jagadeeshan S, Nair SA, Kumar GS.

Int J Nanomedicine. 2011;6:1685-97. doi: 10.2147/IJN.S20165. Epub 2011 Aug 17.

4.

Albumin-based nanocomposite spheres for advanced drug delivery systems.

Misak HE, Asmatulu R, Gopu JS, Man KP, Zacharias NM, Wooley PH, Yang SY.

Biotechnol J. 2014 Jan;9(1):163-70.

PMID:
24106002
5.

Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil.

Yadav AK, Agarwal A, Rai G, Mishra P, Jain S, Mishra AK, Agrawal H, Agrawal GP.

Drug Deliv. 2010 Nov;17(8):561-72. doi: 10.3109/10717544.2010.500635.

PMID:
20738221
6.

Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.

Zhang C, Li G, Wang Y, Cui F, Zhang J, Huang Q.

Int J Pharm. 2012 Oct 15;436(1-2):272-81. doi: 10.1016/j.ijpharm.2012.06.022. Epub 2012 Jun 18. Erratum in: Int J Pharm. 2012 Dec 15;439(1-2):360.

PMID:
22721846
7.

Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles.

Li S, Wang A, Jiang W, Guan Z.

BMC Cancer. 2008 Apr 15;8:103. doi: 10.1186/1471-2407-8-103.

8.

[Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles].

Huang KH, Liu JH, Wang LY, Zhu ZH, Chen QK, Min J, Chen RF.

Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Sep;10(5):482-5. Chinese.

PMID:
17851795
9.

Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.

Yi H, Cho HJ, Cho SM, Lee DG, Abd El-Aty A, Yoon SJ, Bae GW, Nho K, Kim B, Lee CH, Kim JS, Bartlett MG, Shin HC.

BMC Cancer. 2010 May 18;10:211. doi: 10.1186/1471-2407-10-211.

10.

PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.

Li X, Xu Y, Chen G, Wei P, Ping Q.

Drug Dev Ind Pharm. 2008 Jan;34(1):107-15. doi: 10.1080/03639040701484593 .

PMID:
18214762
11.

Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo.

Cheng M, Gao X, Wang Y, Chen H, He B, Li Y, Han J, Zhang Z.

Int J Nanomedicine. 2013;8:4265-76. doi: 10.2147/IJN.S52877. Epub 2013 Nov 6.

12.

Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.

Yin P, Wang Y, Qiu Y, Hou L, Liu X, Qin J, Duan Y, Liu P, Qiu M, Li Q.

Int J Nanomedicine. 2012;7:3961-9. doi: 10.2147/IJN.S32063. Epub 2012 Jul 27.

13.

Pancreatic cancer therapy with a novel pump for controlled drug release.

Haramoto M, Kohno M, Nakajima O, Horibe T, Kiyohara M, Fukazawa H, Togawa T, Kawakami K.

Oncol Rep. 2010 Feb;23(2):365-70.

PMID:
20043096
14.

Formulation and evaluation of drug-loaded targeted magnetic microspheres for cancer therapy.

Enriquez GG, Rizvi SA, D'Souza MJ, Do DP.

Int J Nanomedicine. 2013;8:1393-402. doi: 10.2147/IJN.S43479. Epub 2013 Apr 10.

15.

Controlled release of 5-fluorouracil and progesterone from magnetic nanoaggregates.

Ragab DM, Rohani S, Consta S.

Int J Nanomedicine. 2012;7:3167-89. doi: 10.2147/IJN.S30190. Epub 2012 Jun 29.

16.

Multifunctional magnetic fluorescent hybrid nanoparticles as carriers for the hydrophobic anticancer drug 5-fluorouracil.

Sahu S, Mohapatra S.

Dalton Trans. 2013 Feb 14;42(6):2224-31. doi: 10.1039/c2dt31812a.

PMID:
23197328
17.

Smart multifunctional core-shell nanospheres with drug and gene co-loaded for enhancing the therapeutic effect in a rat intracranial tumor model.

Wang H, Su W, Wang S, Wang X, Liao Z, Kang C, Han L, Chang J, Wang G, Pu P.

Nanoscale. 2012 Oct 21;4(20):6501-8.

PMID:
22961067
18.

Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery.

Zhang Y, Li J, Lang M, Tang X, Li L, Shen X.

J Colloid Interface Sci. 2011 Feb 1;354(1):202-9. doi: 10.1016/j.jcis.2010.10.054. Epub 2010 Oct 28.

PMID:
21094493
19.

Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.

Menei P, Boisdron-Celle M, Croué A, Guy G, Benoit JP.

Neurosurgery. 1996 Jul;39(1):117-23; discussion 123-4.

PMID:
8805147
20.

Preparation and in vitro evaluation of doxorubicin-loaded Fe₃O₄ magnetic nanoparticles modified with biocompatible copolymers.

Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S.

Int J Nanomedicine. 2012;7:511-26. doi: 10.2147/IJN.S24326. Epub 2012 Feb 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk